Shufen Xu
- Molecular Biology
- Cancer Research
- Biomedical Engineering
- Immunology
- Pulmonary and Respiratory Medicine
- Topics
- Cancer-related molecular mechanisms research (7 papers)RNA modifications and cancer (5 papers)Circular RNAs in diseases (4 papers)
In The Last Decade
Shufen Xu
17 papers receiving 412 citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Molecular Biology 290
- Cancer Research 101
- Biomedical Engineering 55
- Immunology 53
- Pulmonary and Respiratory Medicine 36
Countries citing papers authored by Shufen Xu
This map shows the geographic impact of Shufen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufen Xu more than expected).
Fields of papers citing papers by Shufen Xu
This network shows the impact of papers produced by Shufen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufen Xu. The network helps show where Shufen Xu may publish in the future.
Co-authorship network of co-authors of Shufen Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Shufen Xu. A scholar is included among the top collaborators of Shufen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shufen Xu. Shufen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA deliverybreakdown → | 91 |
| 4 | 23 | |
| 5 | Tumor‐Tailored Ionizable Lipid Nanoparticles Facilitate IL‐12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapybreakdown → | 62 |
| 6 | 5 | |
| 7 | 76 | |
| 8 | 9 | |
| 9 | 12 | |
| 10 | 32 | |
| 11 | 10 | |
| 12 | 10 | |
| 13 | 12 | |
| 14 | 26 | |
| 15 | 11 | |
| 16 | 11 | |
| 17 | 17 |
About Shufen Xu
Shufen Xu is a scholar working on Cancer Research, Molecular Biology and Rehabilitation, having authored 17 papers that have together received 419 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (5 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Cancer Research (101 citations), Molecular Biology (290 citations) and Immunology (53 citations). Shufen Xu has collaborated with scholars based in China, Canada and Hong Kong. Frequent co-authors include Andrew Varley, Alex Golubovic, Yue Xu, Bowen Li, Jingan Chen, Rick Xing Ze Lu, Haotian Cui, Bo Wang, Songtao Dong and Shihao Ma. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.